Comparison of the effect of different methods of cyclosporine infusion on transplant-related outcomes in allogeneic transplant recipients
- 24 February 2021
- journal article
- letter
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 27 (3) , 778-779
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Risk factors for relapse after allogeneic transplantation in acute myeloid leukemiaHaematologica, 2015
- Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working GroupTransplantation and Cellular Therapy, 2015
- Comparison of continuous and twice‐daily infusions of cyclosporine A for graft‐versus‐host‐disease prophylaxis in pediatric hematopoietic stem cell transplantationPediatric Blood & Cancer, 2014
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaBlood, 2011
- Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On†Hepatology, 2010
- Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen–Identical Sibling Transplants for Adults With LeukemiaJournal of Clinical Oncology, 2008
- Impact of comorbidity indexes on non-relapse mortalityLeukemia, 2008
- Drug-induced Hyperbilirubinemia and the Clinical Influencing FactorsDrug Metabolism Reviews, 2008
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Chronic graft versus host diseaseBritish Journal of Haematology, 2004